Where does Orna Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Orna Therapeutics, Inc. ranks #24,954 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Orna Therapeutics, Inc. hold?

Orna Therapeutics, Inc. holds 11 US utility patents granted between 2023 and 2025, spanning 10 technology areas.

What is Orna Therapeutics, Inc.'s Innovation Score?

Orna Therapeutics, Inc. has an Innovation Score of 54.0 out of 100 (top 8% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Orna Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Orna Therapeutics, Inc..

What does claim depth mean for Orna Therapeutics, Inc.'s patents?

Orna Therapeutics, Inc.'s patents average 23.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Orna Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Orna Therapeutics, Inc.

Q: What technology areas does Orna Therapeutics, Inc. focus on?

Orna Therapeutics, Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 10 patents. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 10 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Orna ranks #24,954 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 10 technology areas.

#24,954
of 50,000 US assignees by volume: Top 8%
by Innovation Score (54.0/100): 23.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R24954 · US Corporation #24,954 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 11 grants
MID-PACK #24,954/50,000
PHOTO-FINISH Open Drives
CPC-FOCUS A61K · 10 areas
INNOV-PAR 54.0/100
CLAIMS-DENSE 23.7 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Open Drives, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Orna Therapeutics · this assignee

54
3D Lighting Innovati… · lowest

7

What this shows Orna's Innovation Score is 54.0/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Orna's grants concentrate

Orna Therapeutics, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 90.9% of grants classified under A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). Peak complete grant year is 2023 (5 grants) versus a trough of 3 in 2024. By volume, Orna sits between Open Drives, Inc. and Panacea Products Corp..

Orna's three-year grant acceleration

Orna Therapeutics, Inc. shows 8 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Open Drives

11
Optimotion Implan…

11
Optronics Interna…

11
Oriel Therapeutics

11
Own Data

11
Oxford Plastic Sy…

11
Oxicool

11
Panacea Products

11
Orna Therapeutics ◀

11

What this shows Orna holds 11 patents at rank #24,947, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Orna

By rank, the assignees closest to #24,947 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Orna's primary technology class.

Orna's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Orna Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	5	45.5%
2024	3	27.3%
2025partial year	3	27.3%

Which technologies does Orna Therapeutics, Inc. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 10

C07K - PEPTIDES 6

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 6

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 5

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 4

C12Y - ENZYMES 3

A01K - ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS 2

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1

G06N - COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS 1

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#24,954

of 50,000 tracked assignees

Innovation Score

54.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.